Hypoxaemia in patients with heart failure and preserved ejection fraction

Massar Omar, Kazunori Omote, Hidemi Sorimachi, Dejana Popovic, Ardaas Kanwar, Alessio Alogna, Yogesh N.V. Reddy, Kaiser G. Lim, Sanjiv J. Shah, Barry A. Borlaug*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Aims: It is widely held that heart failure (HF) does not cause exertional hypoxaemia, based upon studies in HF with reduced ejection fraction, but this may not apply to patients with HF and preserved ejection fraction (HFpEF). Here, we characterize the prevalence, pathophysiology, and clinical implications of exertional arterial hypoxaemia in HFpEF. Methods and results: Patients with HFpEF (n = 539) and no coexisting lung disease underwent invasive cardiopulmonary exercise testing with simultaneous blood and expired gas analysis. Exertional hypoxaemia (oxyhaemoglobin saturation <94%) was observed in 136 patients (25%). As compared to those without hypoxaemia (n = 403), patients with hypoxaemia were older and more obese. Patients with HFpEF and hypoxaemia had higher cardiac filling pressures, higher pulmonary vascular pressures, greater alveolar–arterial oxygen difference, increased dead space fraction, and greater physiologic shunt compared to those without hypoxaemia. These differences were replicated in a sensitivity analysis where patients with spirometric abnormalities were excluded. Regression analyses revealed that increases in pulmonary arterial and pulmonary capillary pressures were related to lower arterial oxygen tension (PaO2), especially during exercise. Body mass index (BMI) was not correlated with the arterial PaO2, and hypoxaemia was associated with increased risk for death over 2.8 (interquartile range 0.7–5.5) years of follow-up, even after adjusting for age, sex, and BMI (hazard ratio 2.00, 95% confidence interval 1.01–3.96; p = 0.046). Conclusion: Between 10% and 25% of patients with HFpEF display arterial desaturation during exercise that is not ascribable to lung disease. Exertional hypoxaemia is associated with more severe haemodynamic abnormalities and increased mortality. Further study is required to better understand the mechanisms and treatment of gas exchange abnormalities in HFpEF.

Original languageEnglish (US)
Pages (from-to)1593-1603
Number of pages11
JournalEuropean Journal of Heart Failure
Volume25
Issue number9
DOIs
StatePublished - Sep 2023

Funding

Dr. Borlaug is funded by the National Institutes of Health (NIH, R01 HL128526, R01 HL162828, and U01 HL160226) and the United States Department of Defense (W81XWH2210245). Dr. Shah has received research grants from the National Institutes of Health (U54 HL160273, R01 HL107577, R01 HL127028, R01 HL140731, R01 HL149423).

Keywords

  • Gas analysis
  • Heart failure with preserved ejection fraction
  • Hypoxaemia
  • Invasive cardiopulmonary exercise test
  • Outcome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Hypoxaemia in patients with heart failure and preserved ejection fraction'. Together they form a unique fingerprint.

Cite this